Navigation Links
Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

ally in their arms and legs, feel dizzy or lightheaded, or have a fast or irregular heartbeat, as they may be signs of a serious condition called lactic acidosis (buildup of an acid in the blood).

Lactic acidosis is a medical emergency and must be treated in the hospital. Some people who have taken medicines like BARACLUDE have developed serious liver problems called hepatotoxicity. This may occur with liver enlargement (hepatomegaly) and fat in the liver (steatosis).

People should call their healthcare provider right away if they get any of the following signs of liver problems: yellowing (jaundice) of the skin or the white part of the eyes, darkening of the urine, lightening in the color of bowel movements (stools), not feeling like eating food for several days or longer, feeling sick to the stomach (nausea), or having lower stomach pain. Lactic acidosis and hepatotoxicity have happened in some people taking medicines like BARACLUDE.

In some people, hepatitis B symptoms may get worse or become very serious when they stop taking BARACLUDE. People should not stop BARACLUDE without talking to their healthcare provider. Healthcare providers will need to follow their patients and do blood tests to check the liver when BARACLUDE is stopped. People should tell their healthcare provider if they have or develop kidney problems because their healthcare provider may want to do tests to see if a lower dose is needed or a different dose schedule.

Because BARACLUDE is removed from the body through the kidneys, a lower dose or a different dose schedule may be required. Healthcare providers may want to perform tests to determine whether a patient needs a lower dose or should take BARACLUDE less often than once a day.

It is not known if BARACLUDE is safe to use during pregnancy. It is not known if BARACLUDE helps to prevent a pregnant mother from passing HBV to her baby. A pregnant woman and her healthcare provider will need to decide if BARACLUD
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
2. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
3. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
7. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
8. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
9. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
10. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
11. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
Post Your Comments:
(Date:7/29/2015)... Cogentix Medical, Inc. (NASDAQ: CGNT ), a ... release financial results for the first quarter of fiscal year ... on Monday, August 10, 2015. The Company ... results on Monday, August 10, 2015 at 4:30 p.m. Eastern ... and Chief Executive Officer, and Brett Reynolds , Chief ...
(Date:7/29/2015)... N.Y., July 29, 2015  Henry Schein, Inc. ... of health care products and services to office-based ... record second quarter financial results. Net ... were $2.6 billion, an increase of 0.5% compared ... of 7.5% growth in local currencies and a ...
(Date:7/29/2015)... SUNNYVALE, Calif. , July 29, 2015 /PRNewswire/ ... international availability of an update to Xpert® Carba-R, ... genes, OXA-181 and OXA-232.  The on-demand, molecular test ... prevalent mechanisms of carbapenem resistance, namely KPC, NDM, ... commonly referred to as CROs or Superbugs, are ...
Breaking Medicine Technology:Cogentix Medical to Announce First Quarter Fiscal 2016 Results on August 10, 2015 2Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4
... (NASDAQ: TECH ) financial results for the quarter ... First quarter earnings were $27.5 million or $.74 per diluted ... million or $.81 per diluted share after adjustment for intangible ... that was written-up to fair value as part of acquisitions ...
... 25, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. ... leading China-based advanced in-vitro diagnostic ("IVD") company, today ... of its American Depositary Shares ("ADSs") from two ... with the issuance of the Company,s convertible notes ...
Cached Medicine Technology:Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 2Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 3Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 4Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 5Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 6Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 7Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 8China Medical Technologies Recently Received Approximately 2,200,000 of its ADSs from Two Banks which Borrowed the ADSs in Connection With the Issuance of the Company's Convertible Notes in August 2008 2
(Date:7/29/2015)... ... July 29, 2015 , ... Today marks a significant achievement in bringing ... growth companies and is led by a group of experienced investors, has tapped into ... with their dollars to be a part of the fund. The Sofia Fund ...
(Date:7/29/2015)... ... ... is in full swing, which means bridal beauty prep is officially in overdrive. With the ... Every bride wants to look and feel beautiful, but a recent study suggests that brides-to-be ... study by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) , ...
(Date:7/29/2015)... ... July 29, 2015 , ... We are privileged to announce that U.S. News & ... the ninth best ophthalmology hospital in the nation for 2015-2016. This marks the 21st consecutive ... ophthalmology. , “It is an honor to be included in the top 10 ophthalmology ...
(Date:7/29/2015)... York, NY (PRWEB) , ... July 29, 2015 , ... ... were approved by USCIS over the past month! I-829 approvals have been granted to ... in Los Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the Valley ...
(Date:7/29/2015)... ... July 29, 2015 , ... Fastline Publications, Inc., ... 2015 on RFD-TV. , Fastline is dedicated to quality agricultural advertising, both in ... the largest and freshest searchable agriculture equipment database in the world. The site ...
Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2
... for years that psychological trauma that results in ... how a person responds to stress. Now, Cornell ... ones, life-threatening accidents and other such traumas may ... doesn,t develop a clinical disorder., "The findings suggest ...
... The soaring obesity rates across the globe have been ... the 21st century. A top university researcher argues that ... this obesity epidemic. , In an article published in ... examines the vital role physicians play in managing and ...
... often assumed to be the top truants in American medicine, ... and less treatable. However, a new study by Dartmouth researchers ... slip through the cracksat least when it comes to colorectal ... two types of cancer, the study found that urban patients ...
... DALLAS, Nov. 20 Crdentia Corp. (OTC Bulletin,Board: ... the,promotion of Ms. Penny Kirsch to Vice President ... Human Resources Manager,for Crdentia and will continue to ... Kirsch will be responsible for all human resources ...
... RGEN ) announced today that the Company President and ... upcoming,healthcare conferences in New York, NY. -- Lazard Capital ... Wednesday, November 28, 2007 at 11:00 A.M. EST at the ... Avenue, New York, NY. -- BMO Capital Markets Focus ...
... CHICAGO, Nov. 20 Advanced Life Sciences,Holdings, Inc. ... will present at the,Lazard Capital Markets Fourth Annual ... audio. Advanced Life Sciences, management will,provide an overview ... http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO ) The Company,s presentation will ...
Cached Medicine News:Health News:Top researcher argues most physicians aren't prepared to deal with obesity epidemic 2Health News:Rural patients' colon and lung cancers diagnosed earlier, Dartmouth research says 2Health News:Crdentia Announces Promotion of Penny Kirsch to Vice President of Human Resources 2Health News:Crdentia Announces Promotion of Penny Kirsch to Vice President of Human Resources 3Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 2Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 3Health News:Advanced Life Sciences to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 2
... designed for LASIK surgery and other types ... corneal interface and/or stromal bed. Flattened tip ... helps elevate the flap edge. Multiple ports ... x 22mm) Formed 7mm from end. Two ...
... Unique product designed for LASIK ... surgery. Designed to irrigate the corneal ... provides easy insertion under the flap ... Multiple ports provide multi-directional irrigation. 25G ...
For injecting viscoelastic to all meridians of the anterior chamber and to coat intraocular lenses. 20G x 7.8in (.90 x 22mm)....
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 27G x 7/8 in (.40 x 22mm)....
Medicine Products: